Quantifying tumor heterogeneity in whole-genome and whole-exome sequencing data

Bioinformatics

Volumn 30, Issue 24, 2014, Pages 3532-3540

  Oesper, Layla ^a   Satas, Gryte ^a   Raphael, Benjamin J ^a,b  

^a Brown Univerity   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; BREAST TUMOR; DNA SEQUENCE; EXOME; FEMALE; GENE FREQUENCY; GENETICS; GENOMICS; HIGH THROUGHPUT SEQUENCING; HUMAN; LUNG TUMOR; NEOPLASM; PROCEDURES; STATISTICAL MODEL;

ALGORITHMS; BREAST NEOPLASMS; EXOME; FEMALE; GENE FREQUENCY; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 84922732814     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btu651     Document Type: Article

References (23)

1. Albertson, D. G. et al. (2003) Chromosome aberrations in solid tumors. Nat. Genet., 34, 369-376.
2. Andor, N. et al. (2014) Expands: expanding ploidy and allele frequency on nested subpopulations. Bioinformatics, 30, 50-60.
3. Benjamini, Y. and Speed, T. P. (2012) Summarizing and correcting the GC content bias in high-throughput sequencing. Nucleic Acids Res., 40, e72.
4. Cancer Genome Atlas Network. (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
5. Cancer Genome Atlas Research Network. (2013) Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med., 368, 2059-2074.
6. Carter, S. L. et al. (2012) Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol., 30, 413-421.
7. Ding, L. et al. (2010) Analysis of next-generation genomic data in cancer: accomplishments and challenges. Hum. Mol. Genet., 19, R188-R196.
8. Gerlinger, M. et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med., 366, 883-892.
9. Greaves, M. and Maley, C. C. (2012) Clonal evolution in cancer. Nature, 481, 306-313.
10. Gusnanto, A. et al. (2012) Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data. Bioinformatics, 28, 40-47.
11. Hajirasouliha, I. et al. (2014) A combinatorial approach for analyzing intra-tumor heterogeneity from high-throughput sequencing data. Bioinformatics, 30, i78-i86.
12. Jiao, W. et al. (2014) Inferring clonal evolution of tumors from single nucleotide somatic mutations. BMC Bioinformatics, 15, 35.
13. Larson, N. B. and Fridley, B. L. (2013) Purbayes: estimating tumor cellularity and subclonality in next-generation sequencing data. Bioinformatics, 29, 1888-1889.
14. Magi, A. et al. (2013) Excavator: detecting copy number variants from whole-exome sequencing data. Genome Biol., 14, R120.
15. Meyerson, M. et al. (2010) Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet., 11, 685-696.
16. Mullighan, C. G. et al. (2008) Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science, 322, 1377-1380.
17. Nik-Zainal, S. et al. (2012) The life history of 21 breast cancers. Cell, 149, 994-1007.
18. Oesper, L. et al. (2013) THetA: inferring intra-tumor heterogeneity from highthroughput DNA sequencing data. Genome Biol., 14, R80.
19. Roth, A. et al. (2014) Pyclone: statistical inference of clonal population structure in cancer. Nat. Methods, 11, 396-398.
20. Sathirapongsasuti, J. F. et al. (2011) Exome sequencing-based copy-number variation and loss of heterozygosity detection: exomecnv. Bioinformatics, 27, 2648-2654.
21. Sturm, D. et al. (2014) Paediatric and adult glioblastoma: multiform (epi) genomic culprits emerge. Nat. Rev. Cancer, 14, 92-107.
22. Xi, R. et al. (2011) Copy number variation detection in whole-genome sequencing data using the bayesian information criterion. Proc. Natl Acad. Sci. USA, 108, E1128-E1136.
23. Yadav, V. K. and De, S. (2014) An assessment of computational methods for estimating purity and clonality using genomic data derived from heterogeneous tumor tissue samples. In: Brief. Bioinform, in press. [Epub ahead of print, doi:10.1093/bib/bbu002, February 20, 2014].